85 related articles for article (PubMed ID: 17109715)
1. Pisa syndrome-like peculiar posture occurred while running was successfully improved with risperidone.
Harada K; Saito T
Psychiatry Clin Neurosci; 2006 Dec; 60(6):771-2. PubMed ID: 17109715
[No Abstract] [Full Text] [Related]
2. Risperidone-induced tardive dyskinesia.
Silberbauer C
Pharmacopsychiatry; 1998 Mar; 31(2):68-9. PubMed ID: 9562211
[TBL] [Abstract][Full Text] [Related]
3. Improvement of tardive dyskinesia with risperidone: a case report.
Kooptiwoot S; Settachan T
J Med Assoc Thai; 2000 Nov; 83(11):1430-2. PubMed ID: 11215878
[TBL] [Abstract][Full Text] [Related]
4. Treatment of generalized tardive dystonia with clozapine.
Aukst-Margetić B; Margetić B
Psychiatr Danub; 2008 Sep; 20(3):329-31. PubMed ID: 18827758
[TBL] [Abstract][Full Text] [Related]
5. Risperidone treatment of tardive dyskinesia and dystonia.
Chong SA; Remington G; Tan CH
J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
[No Abstract] [Full Text] [Related]
6. Risperidone and tardive dyskinesia in organic psychosis.
Fischer P; Tauscher J; Küfferle B
Pharmacopsychiatry; 1998 Mar; 31(2):70-1. PubMed ID: 9562212
[No Abstract] [Full Text] [Related]
7. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
Marinis TD; Saleem PT; Glue P; Arnoldussen WJ; Teijeiro R; Lex A; Latif MA; Medori R
Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
[TBL] [Abstract][Full Text] [Related]
8. Pisa syndrome resolved after switching to olanzapine.
Nishimura K; Mikami Y; Tsuchibuchi S; Horikawa N
J Neuropsychiatry Clin Neurosci; 2007; 19(2):202-3. PubMed ID: 17431077
[No Abstract] [Full Text] [Related]
9. Increase of risperidone concentration under chlorprothixene comedication--a case report.
Bader W; Greiner C; Haen E
Pharmacopsychiatry; 2008 May; 41(3):116-7. PubMed ID: 18484554
[No Abstract] [Full Text] [Related]
10. Risperidone for tardive dyskinesia.
Chen JY; Bai YM; Pyng LY; Lin CC
Am J Psychiatry; 2001 Nov; 158(11):1931-2. PubMed ID: 11691710
[No Abstract] [Full Text] [Related]
11. Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
Ruhrmann S; Kissling W; Lesch OM; Schmauss M; Seemann U; Philipp M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1012-22. PubMed ID: 17412473
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in the treatment of psychosis and concomitant buccolinguomasticatory dyskinesia in the elderly.
Koponen HJ
Int J Geriatr Psychiatry; 1997 Mar; 12(3):412-3. PubMed ID: 9152730
[No Abstract] [Full Text] [Related]
13. Life-threatening tardive dyskinesia.
Chiu HF; Chung DW; Wing YK; Wong CK
Br J Clin Pract; 1996; 50(3):175-6. PubMed ID: 8733342
[TBL] [Abstract][Full Text] [Related]
14. Propranolol, anxiety, and tardive dyskinesia.
Bacher NA; Lewis HA
J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849
[No Abstract] [Full Text] [Related]
15. Electroconvulsive therapy-associated Pisa syndrome in clozapine treatment.
Lee WK; Shiah IS; Chen CY; Lin TL; Shen LJ
Psychiatry Clin Neurosci; 2008 Dec; 62(6):753. PubMed ID: 19068021
[No Abstract] [Full Text] [Related]
16. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Amiri A; Noorbala AA; Nejatisafa AA; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Hajiazim M; Raznahan M; Akhondzadeh S
Hum Psychopharmacol; 2008 Mar; 23(2):79-86. PubMed ID: 17972359
[TBL] [Abstract][Full Text] [Related]
18. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
